150 related articles for article (PubMed ID: 19065300)
1. Finding of vascular amyloid TTR in inferior nasal concha in a patient with FAP TTRVal30Met.
Munar-Ques M; Martinez-Nadal J; Torres-Rovira JJ; Sole M; Zabay-Becerril JM; Mulet-Ferrer JM
Amyloid; 2008 Dec; 15(4):272-4. PubMed ID: 19065300
[TBL] [Abstract][Full Text] [Related]
2. Value of renal biopsy in the prognosis of liver transplantation in familial amyloid polyneuropathy ATTR Val30Met patients.
Oguchi K; Takei Y; Ikeda S
Amyloid; 2006 Jun; 13(2):99-107. PubMed ID: 16911964
[TBL] [Abstract][Full Text] [Related]
3. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
Ando Y; Terazaki H; Nakamura M; Ando E; Haraoka K; Yamashita T; Ueda M; Okabe H; Sasaki Y; Tanihara H; Uchino M; Inomata Y
Transplantation; 2004 Feb; 77(3):345-9. PubMed ID: 14966406
[TBL] [Abstract][Full Text] [Related]
4. Ocular amyloid angiopathy associated with familial amyloidotic polyneuropathy caused by amyloidogenic transthyretin Y114C.
Kawaji T; Ando Y; Nakamura M; Yamashita T; Wakita M; Ando E; Hirata A; Tanihara H
Ophthalmology; 2005 Dec; 112(12):2212. PubMed ID: 16225929
[TBL] [Abstract][Full Text] [Related]
5. Severe congestive heart failure with cardiac liver cirrhosis 10 years after orthotopic liver transplantation for familial amyloidotic polyneuropathy.
Sakashita N; Ando Y; Haraoka K; Terazaki H; Yamashita T; Nakamura M; Takeya M
Pathol Int; 2006 Jul; 56(7):408-12. PubMed ID: 16792551
[TBL] [Abstract][Full Text] [Related]
6. Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin.
Yazaki M; Tokuda T; Nakamura A; Higashikata T; Koyama J; Higuchi K; Harihara Y; Baba S; Kametani F; Ikeda S
Biochem Biophys Res Commun; 2000 Aug; 274(3):702-6. PubMed ID: 10924339
[TBL] [Abstract][Full Text] [Related]
7. Familial amyloid polyneuropathy in Korea: the first case report with a proven ATTR Lys35Asn gene.
Ryu JK; Baik HW; Bae JS; Hwang TJ; Paik SY; Yu HJ; Choi BO; Takei Y; Ikeda S
Amyloid; 2005 Mar; 12(1):62-4. PubMed ID: 16076613
[TBL] [Abstract][Full Text] [Related]
8. Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology.
Bergström J; Gustavsson A; Hellman U; Sletten K; Murphy CL; Weiss DT; Solomon A; Olofsson BO; Westermark P
J Pathol; 2005 Jun; 206(2):224-32. PubMed ID: 15810051
[TBL] [Abstract][Full Text] [Related]
9. Impact of liver transplantation on familial amyloidotic polyneuropathy (FAP) patients' symptoms and complications.
Suhr OB
Amyloid; 2003 Aug; 10 Suppl 1():77-83. PubMed ID: 14640045
[TBL] [Abstract][Full Text] [Related]
10. Diffuse metabolic changes in the brain of patients with familial amyloid polyneuropathy. A proton MRSI study.
Mazzeo A; Toscano A; Stromillo ML; Battaglini M; Messina C; Federico A; Vita G; De Stefano N
J Neurol Sci; 2006 Jul; 246(1-2):31-5. PubMed ID: 16530227
[TBL] [Abstract][Full Text] [Related]
11. Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model.
Cardoso I; Saraiva MJ
FASEB J; 2006 Feb; 20(2):234-9. PubMed ID: 16449795
[TBL] [Abstract][Full Text] [Related]
12. Deposition of transthyretin amyloid is not accelerated by the same amyloid in vivo.
Wei L; Kawano H; Fu X; Cui D; Ito S; Yamamura K; Ishihara T; Tokuda T; Higuchi K; Maeda S
Amyloid; 2004 Jun; 11(2):113-20. PubMed ID: 15478467
[TBL] [Abstract][Full Text] [Related]
13. Deposition and passage of transthyretin through the blood-nerve barrier in recipients of familial amyloid polyneuropathy livers.
Sousa MM; Ferrão J; Fernandes R; Guimarães A; Geraldes JB; Perdigoto R; Tomé L; Mota O; Negrão L; Furtado AL; Saraiva MJ
Lab Invest; 2004 Jul; 84(7):865-73. PubMed ID: 15122304
[TBL] [Abstract][Full Text] [Related]
14. Long-term quantitative evaluation of liver transplantation in familial amyloid polyneuropathy (Portuguese V30M).
de Carvalho M; Conceição I; Bentes C; Luís ML
Amyloid; 2002 Jun; 9(2):126-33. PubMed ID: 12440485
[TBL] [Abstract][Full Text] [Related]
15. Clinical picture and outcome of transthyretin-related familial amyloid polyneuropathy (FAP) in Japanese patients.
Ikeda S
Clin Chem Lab Med; 2002 Dec; 40(12):1257-61. PubMed ID: 12553427
[TBL] [Abstract][Full Text] [Related]
16. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity.
Ikeda S; Nakazato M; Ando Y; Sobue G
Neurology; 2002 Apr; 58(7):1001-7. PubMed ID: 11940682
[TBL] [Abstract][Full Text] [Related]
17. Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry.
Herlenius G; Wilczek HE; Larsson M; Ericzon BG;
Transplantation; 2004 Jan; 77(1):64-71. PubMed ID: 14724437
[TBL] [Abstract][Full Text] [Related]
18. Cellular consequences of transthyretin deposition.
Saraiva MJ
Amyloid; 2003 Aug; 10 Suppl 1():13-6. PubMed ID: 14640036
[TBL] [Abstract][Full Text] [Related]
19. Clinical and pathological findings of non-Val30Met TTR type familial amyloid polyneuropathy in Japan.
Ikeda S; Takei Y; Tokuda T; Nakazato M; Ando Y
Amyloid; 2003 Aug; 10 Suppl 1():39-47. PubMed ID: 14640041
[TBL] [Abstract][Full Text] [Related]
20. Familial amyloid polyneuropathy and liver transplantation.
Monteiro E; Freire A; Barroso E
J Hepatol; 2004 Aug; 41(2):188-94. PubMed ID: 15288465
[No Abstract] [Full Text] [Related]
[Next] [New Search]
